Form 4: GoodRx Holdings to Repurchase $12.6 Million in Class A Common Stock from Spectrum Equity

GoodRx Holdings will repurchase 3,000,000 shares of Class A Common Stock from Spectrum Equity VII, L.P. and related entities for $12.6 million.

Summary

• GoodRx Holdings, Inc. will repurchase an aggregate of 3,000,000 shares of Class A Common Stock from Spectrum Equity VII, L.P., Spectrum VII Investment Managers' Fund, L.P., and Spectrum VII Co-Investment Fund L.P.
• The total purchase price for the shares is $12,600,000.
• The repurchase is pursuant to a Stock Purchase Agreement dated March 16, 2025.
• In connection with the repurchase, the selling stockholders will convert 3,000,000 shares of Class B Common Stock into Class A Common Stock on a one-for-one basis.
• The closing of the repurchase is expected to occur on March 21, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document describes a stock repurchase, which can be viewed as a positive sign of company confidence, but without further context, it's difficult to assess the overall impact.

Positives

• The repurchase of shares could be seen as a positive signal, indicating the company's confidence in its future prospects.
• The conversion of Class B shares to Class A shares simplifies the capital structure.

Risks

• The impact of the repurchase on the company's financials and stock price remains to be seen.
• The document does not provide any context as to why the repurchase is occurring, which could lead to speculation.

Future Outlook

The repurchase is expected to close on March 21, 2025, but no further forward-looking statements are provided.

Industry Context

Share repurchases are a common mechanism for companies to return capital to shareholders, especially when they believe their stock is undervalued. This move by GoodRx could be interpreted as a sign of management's confidence in the company's future performance.

Related Party Transactions

• The repurchase involves transactions between GoodRx and significant shareholders (Spectrum Equity VII, L.P. and related entities).

Stakeholder Impact

• Shareholders may view the repurchase positively as it can increase earnings per share and potentially boost the stock price.
• The impact on other stakeholders (employees, customers, suppliers, creditors) is not explicitly addressed in the document.

Next Steps

• The repurchase is expected to close on March 21, 2025.

Key Dates